296 related articles for article (PubMed ID: 34659235)
1. Asymptomatic and Mild SARS-CoV-2 Infections Elicit Lower Immune Activation and Higher Specific Neutralizing Antibodies in Children Than in Adults.
Petrara MR; Bonfante F; Costenaro P; Cantarutti A; Carmona F; Ruffoni E; Di Chiara C; Zanchetta M; Barzon L; Donà D; Da Dalt L; Bortolami A; Pagliari M; Plebani M; Rossi P; Cotugno N; Palma P; Giaquinto C; De Rossi A
Front Immunol; 2021; 12():741796. PubMed ID: 34659235
[TBL] [Abstract][Full Text] [Related]
2. Mild SARS-CoV-2 Infections and Neutralizing Antibody Titers.
Bonfante F; Costenaro P; Cantarutti A; Di Chiara C; Bortolami A; Petrara MR; Carmona F; Pagliari M; Cosma C; Cozzani S; Mazzetto E; Di Salvo G; Da Dalt L; Palma P; Barzon L; Corrao G; Terregino C; Padoan A; Plebani M; De Rossi A; Donà D; Giaquinto C
Pediatrics; 2021 Sep; 148(3):. PubMed ID: 34158312
[TBL] [Abstract][Full Text] [Related]
3. Mild and Asymptomatic COVID-19 Convalescents Present Long-Term Endotype of Immunosuppression Associated With Neutrophil Subsets Possessing Regulatory Functions.
Siemińska I; Węglarczyk K; Surmiak M; Kurowska-Baran D; Sanak M; Siedlar M; Baran J
Front Immunol; 2021; 12():748097. PubMed ID: 34659245
[TBL] [Abstract][Full Text] [Related]
4. Early and High SARS-CoV-2 Neutralizing Antibodies Are Associated with Severity in COVID-19 Patients from India.
Shrivastava S; Palkar S; Shah J; Rane P; Lalwani S; Mishra AC; Arankalle VA
Am J Trop Med Hyg; 2021 Jun; 105(2):401-406. PubMed ID: 34138748
[TBL] [Abstract][Full Text] [Related]
5. SARS-CoV-2-Specific Neutralizing Antibody Responses in Norwegian Health Care Workers After the First Wave of COVID-19 Pandemic: A Prospective Cohort Study.
Trieu MC; Bansal A; Madsen A; Zhou F; Sævik M; Vahokoski J; Brokstad KA; Krammer F; Tøndel C; Mohn KGI; Blomberg B; Langeland N; Cox RJ;
J Infect Dis; 2021 Feb; 223(4):589-599. PubMed ID: 33247924
[TBL] [Abstract][Full Text] [Related]
6. Viral loads, lymphocyte subsets and cytokines in asymptomatic, mildly and critical symptomatic patients with SARS-CoV-2 infection: a retrospective study.
Yin SW; Zhou Z; Wang JL; Deng YF; Jing H; Qiu Y
Virol J; 2021 Jun; 18(1):126. PubMed ID: 34118952
[TBL] [Abstract][Full Text] [Related]
7. Humoral signatures of protective and pathological SARS-CoV-2 infection in children.
Bartsch YC; Wang C; Zohar T; Fischinger S; Atyeo C; Burke JS; Kang J; Edlow AG; Fasano A; Baden LR; Nilles EJ; Woolley AE; Karlson EW; Hopke AR; Irimia D; Fischer ES; Ryan ET; Charles RC; Julg BD; Lauffenburger DA; Yonker LM; Alter G
Nat Med; 2021 Mar; 27(3):454-462. PubMed ID: 33589825
[TBL] [Abstract][Full Text] [Related]
8. Persisting Neutralizing Activity to SARS-CoV-2 over Months in Sera of COVID-19 Patients.
Flehmig B; Schindler M; Ruetalo N; Businger R; Bayer M; Haage A; Kirchner T; Klingel K; Normann A; Pridzun L; Tougianidou D; Ranke MB
Viruses; 2020 Nov; 12(12):. PubMed ID: 33260809
[TBL] [Abstract][Full Text] [Related]
9. Quantitative SARS-CoV-2 Serology in Children With Multisystem Inflammatory Syndrome (MIS-C).
Rostad CA; Chahroudi A; Mantus G; Lapp SA; Teherani M; Macoy L; Tarquinio KM; Basu RK; Kao C; Linam WM; Zimmerman MG; Shi PY; Menachery VD; Oster ME; Edupuganti S; Anderson EJ; Suthar MS; Wrammert J; Jaggi P
Pediatrics; 2020 Dec; 146(6):. PubMed ID: 32879033
[TBL] [Abstract][Full Text] [Related]
10. Shedding of infectious SARS-CoV-2 by hospitalized COVID-19 patients in relation to serum antibody responses.
Glans H; Gredmark-Russ S; Olausson M; Falck-Jones S; Varnaite R; Christ W; Maleki KT; Karlberg ML; Broddesson S; Falck-Jones R; Bell M; Johansson N; Färnert A; Smed-Sörensen A; Klingström J; Bråve A
BMC Infect Dis; 2021 May; 21(1):494. PubMed ID: 34044758
[TBL] [Abstract][Full Text] [Related]
11. Characteristics of Anti-SARS-CoV-2 Antibodies in Recovered COVID-19 Subjects.
Huynh A; Arnold DM; Smith JW; Moore JC; Zhang A; Chagla Z; Harvey BJ; Stacey HD; Ang JC; Clare R; Ivetic N; Chetty VT; Bowdish DME; Miller MS; Kelton JG; Nazy I
Viruses; 2021 Apr; 13(4):. PubMed ID: 33923828
[TBL] [Abstract][Full Text] [Related]
12. Dynamics of neutralizing antibody responses to SARS-CoV-2 in patients with COVID-19: an observational study.
Xu X; Nie S; Wang Y; Long Q; Zhu H; Zhang X; Sun J; Zeng Q; Zhao J; Liu L; Li L; Huang A; Hou J; Hou FF
Signal Transduct Target Ther; 2021 May; 6(1):197. PubMed ID: 34006847
[TBL] [Abstract][Full Text] [Related]
13. Kinetics of viral load and antibody response in relation to COVID-19 severity.
Wang Y; Zhang L; Sang L; Ye F; Ruan S; Zhong B; Song T; Alshukairi AN; Chen R; Zhang Z; Gan M; Zhu A; Huang Y; Luo L; Mok CKP; Al Gethamy MM; Tan H; Li Z; Huang X; Li F; Sun J; Zhang Y; Wen L; Li Y; Chen Z; Zhuang Z; Zhuo J; Chen C; Kuang L; Wang J; Lv H; Jiang Y; Li M; Lin Y; Deng Y; Tang L; Liang J; Huang J; Perlman S; Zhong N; Zhao J; Malik Peiris JS; Li Y; Zhao J
J Clin Invest; 2020 Oct; 130(10):5235-5244. PubMed ID: 32634129
[TBL] [Abstract][Full Text] [Related]
14. Long-Term Elevated Inflammatory Protein Levels in Asymptomatic SARS-CoV-2 Infected Individuals.
Tserel L; Jõgi P; Naaber P; Maslovskaja J; Häling A; Salumets A; Zusinaite E; Soeorg H; Lättekivi F; Ingerainen D; Soots M; Toompere K; Kaarna K; Kisand K; Lutsar I; Peterson P
Front Immunol; 2021; 12():709759. PubMed ID: 34603283
[TBL] [Abstract][Full Text] [Related]
15. Low Innate Immunity and Lagged Adaptive Immune Response in the Re-Tested Viral RNA Positivity of a COVID-19 Patient.
Lai C; Liu X; Yan Q; Lv H; Zhou L; Hu L; Cai Y; Wang G; Chen Y; Chai R; Liu Z; Xu Y; Huang W; Xiao F; Hu L; Li Y; Huang J; Zhou Q; Li L; Peng T; Zhang H; Zhang Z; Chen L; Chen C; Ji T
Front Immunol; 2021; 12():664619. PubMed ID: 34305895
[TBL] [Abstract][Full Text] [Related]
16. SARS-CoV-2 elicits robust adaptive immune responses regardless of disease severity.
Nielsen SS; Vibholm LK; Monrad I; Olesen R; Frattari GS; Pahus MH; Højen JF; Gunst JD; Erikstrup C; Holleufer A; Hartmann R; Østergaard L; Søgaard OS; Schleimann MH; Tolstrup M
EBioMedicine; 2021 Jun; 68():103410. PubMed ID: 34098342
[TBL] [Abstract][Full Text] [Related]
17. Dynamic surveillance of SARS-CoV-2 shedding and neutralizing antibody in children with COVID-19.
Liu P; Cai J; Jia R; Xia S; Wang X; Cao L; Zeng M; Xu J
Emerg Microbes Infect; 2020 Dec; 9(1):1254-1258. PubMed ID: 32515685
[TBL] [Abstract][Full Text] [Related]
18. Clinical validation of the Siemens quantitative SARS-CoV-2 spike IgG assay (sCOVG) reveals improved sensitivity and a good correlation with virus neutralization titers.
Irsara C; Egger AE; Prokop W; Nairz M; Loacker L; Sahanic S; Pizzini A; Sonnweber T; Holzer B; Mayer W; Schennach H; Loeffler-Ragg J; Bellmann-Weiler R; Hartmann B; Tancevski I; Weiss G; Binder CJ; Anliker M; Griesmacher A; Hoermann G
Clin Chem Lab Med; 2021 Jul; 59(8):1453-1462. PubMed ID: 33837679
[TBL] [Abstract][Full Text] [Related]
19. Titers of Neutralizing Antibodies against SARS-CoV-2 Are Independent of Symptoms of Non-Severe COVID-19 in Young Adults.
Jonsdottir HR; Bielecki M; Siegrist D; Buehrer TW; Züst R; Deuel JW
Viruses; 2021 Feb; 13(2):. PubMed ID: 33673067
[TBL] [Abstract][Full Text] [Related]
20. Serological Assays Estimate Highly Variable SARS-CoV-2 Neutralizing Antibody Activity in Recovered COVID-19 Patients.
Luchsinger LL; Ransegnola BP; Jin DK; Muecksch F; Weisblum Y; Bao W; George PJ; Rodriguez M; Tricoche N; Schmidt F; Gao C; Jawahar S; Pal M; Schnall E; Zhang H; Strauss D; Yazdanbakhsh K; Hillyer CD; Bieniasz PD; Hatziioannou T
J Clin Microbiol; 2020 Nov; 58(12):. PubMed ID: 32917729
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
